There are two important aspects to this clinical trial.
* First, when you enter this clinical trial you might receive the placebo, rather than the drug.
* Second, this clinical trial has a good feature–once the six month testing period ends– all patients will be eligible to receive Dimebon in an open-label extension trial.
So here is one note to Dawn. Even if you get the placebo during the clinical trial, you will get the Dimebon at the end of the trial period.
http://www.alzheimersreadingroom.com/2009/03/how-do-you-get-dimebon.html
